mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.07 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.07 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.07 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.07 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.07 |